Drawing for RESIDE

USPTO serial 88219032

RESIDE

Reviewed by CopyMark Law Group

Reg. 5811971Status 702Registered
Filing date
Status date
Registration date
Jul 23, 2019
Examiner
BEDNARZ, DUSTIN THOMAS
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with RESIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joan T. Pinaire

Joan T. Pinaire Anywhere Real Estate Inc.175 Park AvenueMadison, NJ 07940United States

Goods and services

ClassDescriptionStatusFirst use
041Publication of electronic magazines and digital content in the field of real estate, not for advertising or promotional purposes; providing non-downloadable digital content in the form of magazines and articles in the real estate fieldACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 25, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 25, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 25, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 23, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 16, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 16, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 5, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Jul 23, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 5, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 22, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 23, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 7, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 7, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 1, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 31, 2019ALIEASSIGNED TO LIE—
Mar 11, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 11, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Mar 11, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 11, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 11, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 6, 2019DOCKASSIGNED TO EXAMINER—
Dec 27, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 10, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance